The real-world efficacy of Cladribine tablets and treatment persistence in people with highly active relapsing multiple sclerosis in Finland – A follow-up study after four years of observation

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 97f278095e49fa49-LAX IP: 47.97.18.252 UTC time: 2025-09-14T20:00:09+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4